Clinical Trial Update: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating CTL-ADV, clinical-grade adenovirus-specific T cells, as immunotherapy after allogeneic stem cell transplantation for adenovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection

Drugs mentioned

• CTL-ADV (Adenovirus-specific T cell therapy)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Adenovirus Infection | Phase 1, Phase 2 | Status: COMPLETED